Mario Biazzi, Founder of Dipharma Group, and His Contribution to the History of NitroglycerinGabriele Razzetti, Global R&D Director at Dipharma, speaks at the conference "Sobrero, Nobel, Biazzi: How Nitroglycerin Changed Geography, History, and Medicine" organized by the Accademia Nazionale delle Scienze detta dei XL
Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USAThe Company expands its range of CGMP services to include small-scale commercial APIs
Dipharma Receives the 2nd GMP Certification from Brazilian ANVISAThe Caronno Pertusella site (Italy) is the second Dipharma manufacturing facility to receive ANVISA certification
Dipharma expands its Italian R&D Center to increase its analytical servicesThe Company strengthens its analytical R&D capabilities,to better support its customers operating in the CDMO and Generics market.
Dipharma completes second phase of CGMP expansion at its Kalamazoo siteThe Company continues to strengthen its capabilities in the North American market
Dipharma receives GMP certification from Brazilian ANVISAThe Baranzate site (Italy) is the first Dipharma manufacturing facility to receive Anvisa certification
